Efficacy and Safety of Sunitinib on Metastatic Renal Cell Carcinoma: A Single-Institution Experience

PURPOSE: We assessed the efficacy and safety of the tyrosine kinase inhibitor sunitinib in Korean patients with metastatic renal cell carcinoma (mRCC). MATERIALS AND METHODS: Between September 2007 and December 2009, all twenty-one patients who had mRCC with a clear-cell component were retrospective...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hwang, Eugene, Lee, Hyo Jin, Sul, Chong Koo, Lim, Jae Sung
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Urological Association 2010
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2907492/
https://ncbi.nlm.nih.gov/pubmed/20664776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/kju.2010.51.7.450
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak